JPS5387367A - Piperidine derivative - Google Patents

Piperidine derivative

Info

Publication number
JPS5387367A
JPS5387367A JP147578A JP147578A JPS5387367A JP S5387367 A JPS5387367 A JP S5387367A JP 147578 A JP147578 A JP 147578A JP 147578 A JP147578 A JP 147578A JP S5387367 A JPS5387367 A JP S5387367A
Authority
JP
Japan
Prior art keywords
piperidine derivative
piperidine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP147578A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6125031B2 (sv
Inventor
Jibukobitsuku Dousan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of JPS5387367A publication Critical patent/JPS5387367A/ja
Publication of JPS6125031B2 publication Critical patent/JPS6125031B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP147578A 1977-01-11 1978-01-10 Piperidine derivative Granted JPS5387367A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB931/77A GB1542823A (en) 1977-01-11 1977-01-11 Piperidine derivatives

Publications (2)

Publication Number Publication Date
JPS5387367A true JPS5387367A (en) 1978-08-01
JPS6125031B2 JPS6125031B2 (sv) 1986-06-13

Family

ID=9713045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP147578A Granted JPS5387367A (en) 1977-01-11 1978-01-10 Piperidine derivative

Country Status (22)

Country Link
JP (1) JPS5387367A (sv)
BE (1) BE862769A (sv)
BG (1) BG28574A3 (sv)
CA (1) CA1101426A (sv)
CS (1) CS195652B2 (sv)
DD (1) DD134089A5 (sv)
DE (1) DE2800919A1 (sv)
DK (1) DK5778A (sv)
ES (1) ES465861A1 (sv)
FI (1) FI780028A (sv)
FR (1) FR2376846A1 (sv)
GB (1) GB1542823A (sv)
IL (1) IL53766A0 (sv)
IT (1) IT1103117B (sv)
LU (1) LU78839A1 (sv)
NL (1) NL7800146A (sv)
NO (1) NO780040L (sv)
PL (1) PL203912A1 (sv)
PT (1) PT67511B (sv)
SE (1) SE7800184L (sv)
SU (2) SU772482A3 (sv)
ZA (1) ZA78158B (sv)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103972A1 (ja) * 2003-05-20 2004-12-02 Ajinomoto Co.,Inc. 新規ピペリジン誘導体
JP2006516149A (ja) * 2002-12-18 2006-06-22 エフ　エム　シー　コーポレーション Ｎ−（置換アリールメチル）−４−（二置換メチル）ピペリジン及びピリジン

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650874A (en) * 1984-11-26 1987-03-17 G. D. Searle & Co. N-(aralkoxybenzyl)-4(benzhydryl) piperidines
US4628095A (en) * 1985-06-05 1986-12-09 G. D. Searle & Co. Substituted N-benzyl-4-(benzhydryl) piperidines
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
WO1997022583A1 (de) * 1995-12-20 1997-06-26 Eckhart Pein Neue 1-phenylalkyl/alkylen-4-(.alpha.-hydroxydiphenylmethyl)-piperidin derivate und ihre verwendung als serotonin antagonisten
DE69924467T2 (de) 1998-01-16 2006-02-16 Eisai Co., Ltd. Verfahren zur herstellung von donepezilderivaten

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516149A (ja) * 2002-12-18 2006-06-22 エフ　エム　シー　コーポレーション Ｎ−（置換アリールメチル）−４−（二置換メチル）ピペリジン及びピリジン
WO2004103972A1 (ja) * 2003-05-20 2004-12-02 Ajinomoto Co.,Inc. 新規ピペリジン誘導体
JPWO2004103972A1 (ja) * 2003-05-20 2006-07-20 味の素株式会社 新規ピペリジン誘導体
US7683077B2 (en) 2003-05-20 2010-03-23 Ajinomoto Co., Inc. Piperidine derivative
JP4730096B2 (ja) * 2003-05-20 2011-07-20 味の素株式会社 新規ピペリジン誘導体

Also Published As

Publication number Publication date
SE7800184L (sv) 1978-07-12
PT67511A (fr) 1978-02-01
NL7800146A (nl) 1978-07-13
LU78839A1 (fr) 1978-09-18
IT7847573A0 (it) 1978-01-10
GB1542823A (en) 1979-03-28
CS195652B2 (en) 1980-02-29
SU772482A3 (ru) 1980-10-15
ZA78158B (en) 1978-10-25
IL53766A0 (en) 1978-04-30
BG28574A3 (en) 1980-05-15
CA1101426A (en) 1981-05-19
FR2376846B1 (sv) 1983-02-04
ES465861A1 (es) 1978-09-16
SU990761A1 (ru) 1983-01-23
DD134089A5 (de) 1979-02-07
FI780028A (fi) 1978-07-12
FR2376846A1 (fr) 1978-08-04
NO780040L (no) 1978-07-12
BE862769A (fr) 1978-07-10
PL203912A1 (pl) 1979-06-04
JPS6125031B2 (sv) 1986-06-13
IT1103117B (it) 1985-10-14
PT67511B (fr) 1979-06-11
DE2800919A1 (de) 1978-07-13
DK5778A (da) 1978-07-12

Similar Documents

Publication Publication Date Title
JPS5390251A (en) Hexahydroterphenyl derivative
JPS5377069A (en) Piperidine derivative
IL59158A0 (en) Piperidine derivatives
IL59157A0 (en) Piperidine derivatives
JPS5387364A (en) Piperidine derivative
JPS5387365A (en) Piperidine derivative
JPS53105475A (en) Pyrolidine derivative
JPS5392786A (en) Novel aminoalkoxyphenyl derivative
JPS52113978A (en) Novel piperidine derivative
JPS5492974A (en) 44aminoquinoline derivative
JPS5398993A (en) Oxadiazoropyrimidine derivative
JPS5473779A (en) 22iminooimidazolidine derivative
JPS5448751A (en) 255alkylcholesterol derivative
JPS5387367A (en) Piperidine derivative
GB2044254B (en) Piperidine derivatives
JPS5398992A (en) Oxadiazoropyrimidine derivative
JPS543030A (en) Trioxyacylophenone derivative
JPS53108935A (en) 22hydroxyynnpropylamine derivative
GB2007219B (en) 4-phenyl-thieno piperidine derivatives
JPS52122378A (en) Piperidine derivative
JPS549243A (en) Ll or dllphenylglycine derivative
JPS5432495A (en) Benzoobisthiazole derivative
JPS5424884A (en) Tetrahydroosstriazinethione derivative
JPS545954A (en) 155substituteddomegaa pentanoylprostaglandin derivative
JPS53105486A (en) Pyridyllpiperazine derivative